Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples